A class of balanced dual-band bandpass filters (BPFs) with planar transversal-signal-interference coupled-line sections is reported. In their building balanced dual-band BPF stage under differential-mode excitation, a second-order quasi-elliptic-type dual-band bandpass filtering transfer function is obtained. Specifically, from the transversal interaction among their two open-ended and virtually-short-ended half-wavelength coupled-line paths, sharp-rejection differential-mode dual passbands with several out-of-band transmission zeros at both sides are realized. To attain high common-mode suppression levels within the differential-mode passbands, two open-ended line segments are connected at the symmetry plane of the devised balanced dual-band BPF stage. Moreover, higher-order schemes based on in-series-cascaded multi-stage designs to further increase differential-mode selectivity and in-band common-mode rejection are illustrated. The operational principles and parametric-analysis design rules of the engineered transversal-coupled-line-based balanced dual-band BPF approach are detailed. Additionally, for a rigorous interpretation of their zero/pole characteristics, a digital-modeling framework is applied to them to connect RF balanced filters with their discrete-time versions. For practical-validation purposes, a microstrip prototype of two-stage/fourth-order balanced dual-band BPF is built and tested. It exhibits measured differential-mode dual passbands with center frequencies of 1.464 GHz and 2.294 GHz, 3-dB fractional bandwidths of 8.74% and 9.68%, and in-band common-mode rejection levels above 23.16 dB and 31.36 dB, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.